InsidersTradesSigma
Follow the IMPEL PHARMACEUTICALS INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 19 December 2023 (Cession). Among the most active insiders: Vivo Capital VIII, LLC. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IMPEL PHARMACEUTICALS INC 是一家专注于开发神经系统疾病创新疗法的公司。它旨在提供改善患者生活质量的治疗解决方案。